Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23241,79,1.03 [0.81-1.32],0.7862490300870141
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23728,126,0.95 [0.77-1.16],0.6019407046124776
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23519,867,1.03 [0.96-1.11],0.3906612044910067
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Candidiasis,23745,261,0.97 [0.84-1.11],0.6224972144863793
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23070,2337,1.02 [0.98-1.07],0.3301726534908572
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23292,1765,1.03 [0.98-1.08],0.2506046771961929
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23574,844,1.00 [0.92-1.08],0.9449827565072392
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23682,37,1.23 [0.91-1.66],0.1717479785523062
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22662,538,0.94 [0.85-1.03],0.1884536137899826
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21906,516,1.01 [0.92-1.11],0.8459989632789777
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22122,148,0.93 [0.77-1.13],0.4870893049968233
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17617,1023,1.02 [0.95-1.09],0.589688894795946
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21925,249,1.11 [0.98-1.27],0.0945513931585817
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23718,988,0.99 [0.92-1.06],0.797588435600394
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Mycoses,23801,317,0.97 [0.85-1.10],0.6421639881660839
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23180,528,1.08 [0.99-1.18],0.0950772345967929
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23751,589,0.95 [0.87-1.05],0.3312181138911911
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22858,128,0.93 [0.76-1.15],0.5030703563141763
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23842,28,1.05 [0.70-1.57],0.8202110999193806
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23681,519,0.95 [0.86-1.05],0.2870303933694188
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23709,64,0.81 [0.58-1.11],0.1925037924355025
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23752,152,1.11 [0.94-1.31],0.2041331637624721
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23738,138,1.13 [0.95-1.33],0.1648046396092683
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22946,294,0.98 [0.86-1.12],0.7782595356685593
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22858,206,1.00 [0.85-1.16],0.9567060096319312
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22797,67,0.94 [0.70-1.25],0.6479253344779424
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23816,43,0.70 [0.46-1.07],0.1027498914971836
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23787,112,0.77 [0.60-0.99],0.0385396695168967
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral warts,23712,37,0.50 [0.30-0.84],0.0091861347906038
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23718,43,0.98 [0.70-1.38],0.9085187768741168
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm,23585,271,0.99 [0.86-1.13],0.8485100560907022
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23765,62,1.09 [0.84-1.41],0.4991673026125205
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23740,66,1.06 [0.82-1.37],0.6504867466677927
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10630,36,1.15 [0.83-1.58],0.4039383034266823
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23663,997,1.00 [0.93-1.07],0.986127723875624
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of meninges,23831,44,1.07 [0.78-1.47],0.6718034874382808
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23811,46,0.97 [0.69-1.35],0.8455479738155145
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23822,79,1.14 [0.92-1.42],0.2371436340650324
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of ovary,13155,83,0.89 [0.68-1.16],0.3872997541883418
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23834,234,0.95 [0.82-1.11],0.5204431081842071
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Caecum,23830,181,0.90 [0.75-1.08],0.2525069962709135
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23775,45,1.14 [0.85-1.53],0.387463768845868
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Descending colon,23838,154,0.90 [0.75-1.10],0.3086255594451579
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Rectum,23804,242,0.97 [0.84-1.13],0.7210464473340505
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23772,465,0.99 [0.89-1.10],0.8678227721933195
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23834,259,0.85 [0.73-0.99],0.0380831759385835
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Carcinoma in situ of breast,11293,74,0.86 [0.65-1.15],0.3211877170317467
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11332,84,1.01 [0.79-1.28],0.9331976639027232
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20582,31,1.14 [0.81-1.62],0.4551730625189075
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20584,33,0.93 [0.62-1.40],0.74024125529117
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23803,93,0.92 [0.72-1.18],0.5223540617486488
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Haemangioma, any site",23803,91,0.94 [0.73-1.19],0.5976795888149493
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Leiomyoma of uterus,12603,340,1.02 [0.90-1.14],0.7717599140016773
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Lung cancer and mesothelioma,17659,147,0.95 [0.79-1.15],0.6288266794171167
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Lymphoid leukaemia,20577,26,1.09 [0.73-1.62],0.6659380911412448
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20678,127,1.08 [0.90-1.29],0.4050547481933887
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20626,75,0.95 [0.74-1.24],0.7239712540044629
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11378,66,0.93 [0.69-1.25],0.6225470327181722
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20596,45,0.89 [0.62-1.27],0.5174644896934475
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20601,50,0.86 [0.61-1.22],0.3990660960125951
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20614,63,1.03 [0.79-1.35],0.8135246845657422
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11359,47,0.89 [0.63-1.27],0.5321243690727553
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20600,49,0.96 [0.69-1.33],0.8103711028133416
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9580,341,1.02 [0.91-1.15],0.6883731663765772
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20635,84,1.12 [0.90-1.39],0.3135933142566453
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20597,46,0.97 [0.69-1.35],0.8348121240278509
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20607,56,0.96 [0.71-1.30],0.7827409028892681
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Melanocytic naevi,23642,190,1.11 [0.96-1.28],0.1715384050578018
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Melanocytic naevi of trunk,23803,87,1.14 [0.92-1.40],0.2290198447795382
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Melanoma in situ,20559,37,1.34 [1.02-1.76],0.0383618713704416
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20604,53,1.11 [0.84-1.46],0.4682939486088977
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20651,100,1.09 [0.89-1.34],0.4122898790757406
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20649,98,1.07 [0.86-1.32],0.5493817620941227
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20607,56,1.03 [0.77-1.37],0.8385880160666827
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Other benign neoplasms of skin,23685,128,0.94 [0.77-1.15],0.5664315218563112
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21101,550,0.94 [0.85-1.04],0.2133407496528092
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21131,580,0.95 [0.87-1.05],0.3080022515716075
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23596,255,0.93 [0.80-1.08],0.3340527059515337
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22623,39,1.08 [0.77-1.50],0.6662206958157117
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23407,66,1.00 [0.76-1.31],0.9970347150646268
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23145,1905,1.03 [0.99-1.09],0.1707058790777582
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22853,19,0.75 [0.41-1.39],0.3646109384262641
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23540,28,1.38 [1.02-1.87],0.0354757197873141
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23458,874,1.03 [0.96-1.11],0.4330347105933961
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23458,874,1.03 [0.96-1.11],0.4330347105933961
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22632,48,1.18 [0.89-1.55],0.2502316835453536
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23604,770,1.02 [0.94-1.10],0.5996432553848878
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23600,88,1.30 [1.08-1.56],0.0055013916137095
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23388,47,1.12 [0.83-1.50],0.4555774319845779
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23379,38,1.09 [0.78-1.52],0.5973324264650501
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23677,165,1.04 [0.88-1.23],0.6311523912695687
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23772,60,1.06 [0.81-1.39],0.654436888805195
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23654,142,1.04 [0.86-1.24],0.7042664031729509
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22892,58,0.97 [0.72-1.31],0.8346967056293627
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20448,176,0.92 [0.77-1.10],0.3831647307770648
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22166,104,1.16 [0.96-1.40],0.1361759121929784
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22184,122,1.17 [0.99-1.39],0.06435284936505
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20303,31,1.21 [0.87-1.69],0.2607959242935247
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22126,64,1.02 [0.77-1.34],0.9037679037718536
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21820,126,1.05 [0.87-1.27],0.6200634794534622
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23714,139,1.08 [0.91-1.29],0.3704262592076305
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23620,45,0.87 [0.61-1.25],0.4579913019957179
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23607,32,1.18 [0.85-1.65],0.3282539092932833
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23488,1426,1.05 [0.99-1.11],0.1036936927217753
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21349,1386,1.04 [0.98-1.10],0.158425114204101
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20311,39,1.17 [0.85-1.59],0.3331463717975672
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22422,50,0.91 [0.65-1.27],0.5714377688762293
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20432,160,1.12 [0.96-1.32],0.1458045693955258
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20325,53,1.01 [0.75-1.36],0.9631426263711512
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22349,2077,1.03 [0.98-1.08],0.1843340910771313
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20378,106,0.96 [0.77-1.20],0.7467625422565873
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20609,337,1.05 [0.93-1.18],0.4404378121964759
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23760,226,1.11 [0.97-1.27],0.1269614965084396
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23626,92,1.22 [1.01-1.48],0.0393152170857145
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20362,90,1.04 [0.82-1.30],0.7618122742951743
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20306,34,1.13 [0.80-1.59],0.47865867874685
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23472,1100,1.02 [0.96-1.09],0.5205489270251014
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20381,109,0.90 [0.71-1.13],0.3530100691704125
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20400,128,1.04 [0.86-1.26],0.704536723211692
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20614,342,0.86 [0.76-0.99],0.0326089197016173
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20328,56,0.81 [0.57-1.14],0.2235246800462187
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23620,86,1.23 [1.01-1.50],0.0404325833423273
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20532,260,1.05 [0.92-1.20],0.4363523112176147
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20540,268,1.15 [1.02-1.29],0.0240465897413881
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21742,48,1.20 [0.92-1.57],0.1805514614295767
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23238,2966,1.02 [0.98-1.07],0.2430668262732986
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22395,23,1.01 [0.64-1.59],0.9663474046767994
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22424,52,0.99 [0.73-1.34],0.9503441090744028
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23686,1674,0.95 [0.90-1.01],0.0815112612309977
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23688,1670,0.95 [0.90-1.00],0.0732526685223295
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22403,31,1.32 [0.98-1.77],0.0705838499164443
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23562,1068,1.00 [0.94-1.07],0.933370518725118
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21046,774,1.07 [0.99-1.15],0.0909502184446509
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23836,105,1.06 [0.86-1.31],0.5612386266886831
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23606,31,1.02 [0.69-1.51],0.9328468348798652
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22571,77,1.04 [0.81-1.32],0.7709289229948875
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22593,99,1.03 [0.83-1.28],0.7795191101490284
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20381,109,1.03 [0.84-1.27],0.7910814683172699
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22283,105,1.12 [0.92-1.37],0.2570640223999557
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1485,57,0.80 [0.56-1.13],0.2053648113893045
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1581,166,1.07 [0.90-1.26],0.4571232416240429
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22213,35,0.98 [0.69-1.39],0.9118513050969108
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1457,29,1.09 [0.74-1.60],0.678901289966889
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23488,1310,1.02 [0.96-1.09],0.4946713081183372
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23634,59,0.82 [0.58-1.14],0.2301025094146204
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21939,245,0.95 [0.82-1.10],0.4894300945410915
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20618,346,1.04 [0.93-1.17],0.5249270691545772
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23760,147,1.00 [0.84-1.20],0.9856760356257256
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23191,49,1.04 [0.76-1.40],0.8186944811776069
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Angina pectoris,22748,691,0.95 [0.87-1.04],0.2781256529155035
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23235,93,1.08 [0.88-1.34],0.4559129266492362
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23169,27,0.93 [0.59-1.46],0.7462789781324248
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23236,94,1.02 [0.81-1.27],0.8952389206910059
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16926,787,1.04 [0.96-1.12],0.3377324480883326
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,AV-block,21700,158,1.01 [0.84-1.20],0.9509867630435812
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23812,225,0.98 [0.85-1.14],0.8183636507581205
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Cardiac arrest,16231,92,1.04 [0.83-1.30],0.7408029627142962
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21656,114,0.96 [0.78-1.20],0.7430635516654089
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21614,72,0.95 [0.72-1.25],0.707554560240151
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23844,15,0.78 [0.39-1.54],0.4699974851468294
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Conduction disorders,22006,464,0.95 [0.86-1.06],0.3852510005710078
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23215,1166,1.02 [0.96-1.08],0.5924360415352363
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22143,5225,1.01 [0.98-1.04],0.6108161135156913
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22836,154,0.98 [0.82-1.18],0.860344364513115
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Endocarditis,21582,40,0.90 [0.62-1.32],0.6035410780408685
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23735,442,1.01 [0.91-1.13],0.8088847059997655
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Hypertension,22635,4257,1.01 [0.98-1.04],0.5979481391169881
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22643,4265,1.01 [0.97-1.04],0.6272959081990777
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23692,48,0.85 [0.59-1.22],0.3772003665265709
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18457,79,0.96 [0.74-1.25],0.7647449474615962
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18417,39,1.20 [0.89-1.63],0.2332879875785789
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Hypotension,23757,591,1.02 [0.93-1.12],0.6503717306835215
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23384,57,1.19 [0.92-1.53],0.1783972407509779
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23352,1295,1.00 [0.94-1.06],0.9839808325675576
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23649,270,1.04 [0.91-1.19],0.5414143318899429
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21724,182,1.09 [0.94-1.27],0.2591862481163121
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23623,523,1.01 [0.92-1.11],0.8288999903028331
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22482,425,1.01 [0.91-1.12],0.8505489309146286
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23793,105,0.91 [0.72-1.15],0.4207443317500614
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23829,182,1.05 [0.89-1.23],0.5682420863713907
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Oesophageal varices,22713,31,0.87 [0.56-1.35],0.5228678920170404
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other aneurysm,23181,39,0.91 [0.62-1.33],0.615665370430011
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other arrhythmias,21764,222,1.00 [0.87-1.17],0.9495681908795046
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23201,59,0.92 [0.68-1.26],0.6211886814830268
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23270,128,1.12 [0.94-1.34],0.2013268359406529
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21653,111,0.84 [0.67-1.07],0.1622523700212285
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other disorders of veins,22743,61,0.74 [0.53-1.05],0.0926146049865486
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22727,45,0.97 [0.70-1.37],0.8827469415306247
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23162,34,0.75 [0.47-1.18],0.2102413088664402
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22760,78,1.05 [0.82-1.34],0.7192161484620136
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22054,512,1.06 [0.96-1.16],0.2332659683028779
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23206,40,0.77 [0.50-1.17],0.216971186102539
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23444,302,1.04 [0.92-1.18],0.539220614857514
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23454,137,1.00 [0.82-1.21],0.9790124798286538
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23333,205,1.02 [0.87-1.19],0.814759453286576
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16345,206,1.05 [0.91-1.22],0.492414351362785
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23302,181,0.96 [0.81-1.14],0.6176542968012978
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22897,215,1.07 [0.93-1.23],0.3472831277708837
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23603,286,0.91 [0.79-1.04],0.1684818392780322
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23806,282,1.04 [0.91-1.18],0.5730475978296246
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21687,145,0.78 [0.63-0.97],0.0261104763863773
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23451,134,1.01 [0.83-1.22],0.9401345004738751
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23225,97,1.01 [0.81-1.26],0.9483633360339466
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23643,316,1.04 [0.92-1.18],0.5067092910403517
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23621,348,1.03 [0.92-1.16],0.5682182656054813
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23365,50,1.08 [0.81-1.45],0.6049714959517116
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23190,49,0.99 [0.72-1.35],0.9435308897901205
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23494,115,1.02 [0.83-1.25],0.8502078432185946
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23257,157,1.04 [0.88-1.23],0.6607333171698624
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Varicose veins,22951,269,0.99 [0.87-1.14],0.9092462528352389
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23152,45,1.07 [0.79-1.46],0.6498649016783158
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23686,449,0.96 [0.86-1.07],0.4414560925787583
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23700,319,1.03 [0.91-1.16],0.681050039631274
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21232,1225,1.01 [0.95-1.08],0.6836242536192934
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,Any mental disorder,23183,3176,1.01 [0.97-1.05],0.7440810302376708
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23646,371,1.05 [0.94-1.17],0.3941516629364071
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21464,1457,1.04 [0.99-1.10],0.1429297061688035
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20084,77,0.83 [0.63-1.11],0.217598273320944
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,Smoking dependency,23363,1328,0.97 [0.91-1.03],0.3825190488349362
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21528,1521,0.98 [0.93-1.04],0.5532523687054898
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,Vascular dementia,23745,17,0.86 [0.47-1.55],0.6068421441411944
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Alzheimer disease,23843,63,0.96 [0.72-1.28],0.7779659820202286
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Bell's palsy,22397,68,0.84 [0.62-1.13],0.2529274209902705
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22748,419,0.98 [0.88-1.10],0.7350285008861572
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Cerebral cysts,23529,178,0.98 [0.83-1.16],0.7867617332083716
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23768,187,1.06 [0.90-1.23],0.4922854876101151
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23714,22,1.06 [0.68-1.65],0.8097727251057875
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23833,49,1.10 [0.83-1.47],0.5029512065179906
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23403,52,0.96 [0.70-1.31],0.7766670694290951
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Epilepsy,22493,222,1.07 [0.93-1.23],0.3331519037816954
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23418,1147,1.04 [0.98-1.11],0.1772109225730646
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23816,167,0.99 [0.84-1.18],0.9320406235835396
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23398,1424,0.97 [0.91-1.03],0.3184659829109715
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Generalized epilepsy,23518,44,0.86 [0.59-1.24],0.4108640177727591
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Hemiplegia,23717,136,1.03 [0.86-1.24],0.7398466964375552
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Hydrocephalus,23395,44,1.19 [0.89-1.58],0.2338742933294738
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23822,59,0.92 [0.68-1.25],0.6014754224568211
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22393,64,0.99 [0.75-1.31],0.9489919494787494
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22399,70,0.82 [0.61-1.11],0.208417008650736
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Memory loss,23713,65,0.87 [0.64-1.18],0.3611653685080735
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Migraine,22632,361,1.03 [0.92-1.16],0.5825600053067446
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23767,327,1.05 [0.93-1.18],0.4248758835209434
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Motor neuron disease,17327,91,1.00 [0.80-1.26],0.9907304870372932
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23658,130,1.08 [0.91-1.29],0.3827699047227033
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23314,985,0.99 [0.92-1.06],0.749197172748364
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Neurological diseases,22578,2631,1.01 [0.97-1.06],0.5908974040506145
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23757,65,1.05 [0.80-1.36],0.7274051668845947
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22664,335,1.00 [0.89-1.13],0.9631092390096448
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23784,203,1.02 [0.87-1.18],0.8436892419959136
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19877,276,1.05 [0.92-1.19],0.4529167068282483
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23403,52,1.04 [0.77-1.39],0.8040570548350866
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23453,102,0.99 [0.80-1.24],0.9629934305300502
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23720,71,0.97 [0.74-1.27],0.8492812891025429
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22415,86,0.84 [0.64-1.10],0.2016529617302972
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other headache syndromes,22327,56,1.28 [1.02-1.62],0.0339016410024097
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other neurological diseases,23736,385,1.03 [0.92-1.15],0.6453824804210404
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other sleep disorders,22774,503,1.03 [0.93-1.13],0.5574561711870845
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Parkinson's disease,23830,75,1.07 [0.84-1.36],0.5949892906746698
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23406,55,0.96 [0.71-1.31],0.7910366876341848
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Restless leg syndrome,23842,33,1.16 [0.82-1.64],0.3883751697500865
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Sleep apnoea,23635,442,1.04 [0.94-1.15],0.4516414265523114
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23613,32,1.12 [0.79-1.59],0.5174872466096435
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23828,115,0.97 [0.79-1.20],0.801855660475238
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22356,27,1.07 [0.72-1.59],0.7380850132145265
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23843,64,0.96 [0.72-1.27],0.778751860386785
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23733,16,0.84 [0.45-1.57],0.5905665827168713
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23418,34,0.89 [0.58-1.34],0.5643517849472603
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23528,185,1.29 [1.13-1.46],0.0001005286847426
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23772,168,1.09 [0.93-1.28],0.2685218473999991
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23189,33,0.95 [0.64-1.42],0.8047201523405959
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23222,66,0.97 [0.73-1.28],0.8203808872716707
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23760,29,0.60 [0.34-1.04],0.0671974824456386
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23677,58,1.25 [0.98-1.58],0.0675400732127261
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1460,32,1.19 [0.84-1.68],0.3188390978433832
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1725,68,0.91 [0.68-1.22],0.5271492960009041
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23459,75,0.86 [0.65-1.14],0.300392247048699
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23738,540,1.06 [0.96-1.16],0.2378525833852053
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23570,414,0.90 [0.80-1.02],0.0874943954832167
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23276,120,1.01 [0.83-1.23],0.9456779089296647
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23762,419,1.14 [1.03-1.25],0.0080618534448802
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23835,50,0.78 [0.54-1.13],0.1839668197381588
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23696,353,1.17 [1.06-1.30],0.0020085544135308
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23807,188,0.94 [0.79-1.11],0.476339005267583
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23789,116,0.88 [0.70-1.10],0.2562732774993794
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23171,15,0.56 [0.26-1.24],0.1528026613400536
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23182,26,0.81 [0.49-1.34],0.4079483673689044
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23186,30,1.08 [0.75-1.57],0.6696430215771902
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23803,331,1.08 [0.96-1.21],0.2122031544597775
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23552,80,1.05 [0.83-1.33],0.6821246467874247
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23364,21,1.18 [0.78-1.79],0.4456395601594995
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23679,60,0.76 [0.54-1.07],0.1178867069629167
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23749,130,1.02 [0.84-1.23],0.8783386864408267
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23489,146,1.02 [0.85-1.22],0.8106869068768223
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23739,66,0.80 [0.58-1.10],0.1742168001590245
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23687,215,1.10 [0.95-1.26],0.1921225282411479
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23482,98,1.02 [0.82-1.27],0.8248659432567448
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23224,926,1.03 [0.96-1.10],0.4453024120238668
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23727,108,1.08 [0.88-1.32],0.4511351606993786
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23821,97,0.95 [0.75-1.20],0.6493023603750866
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23384,228,0.88 [0.75-1.03],0.1209409314576806
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23655,36,0.53 [0.31-0.89],0.0157163246136915
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23819,34,0.82 [0.53-1.27],0.382019563221179
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23192,36,1.14 [0.82-1.58],0.4390860739701979
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23256,100,1.01 [0.81-1.26],0.9280872863859754
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23255,57,0.95 [0.70-1.29],0.7370524694919608
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23391,48,1.03 [0.75-1.40],0.8754366866406348
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23241,43,0.95 [0.67-1.35],0.7904365083263081
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23518,46,0.92 [0.65-1.30],0.6343627822724494
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23553,81,0.79 [0.59-1.06],0.1138794240088336
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23231,75,0.73 [0.53-1.00],0.0471716767572093
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23302,104,1.22 [1.03-1.46],0.0237635730259533
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23227,29,0.62 [0.36-1.07],0.0880945681017677
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23018,720,1.12 [1.04-1.21],0.0023638303514926
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23200,44,1.01 [0.73-1.40],0.9619639457518236
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23652,268,0.98 [0.85-1.12],0.734336449735592
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23415,31,1.03 [0.70-1.52],0.8631145225210897
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23494,110,0.83 [0.66-1.06],0.140748617233772
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23667,58,1.12 [0.86-1.45],0.4131694904255266
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23803,78,0.91 [0.69-1.18],0.4682983286460934
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23734,122,0.95 [0.77-1.17],0.6008935679422388
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23658,49,0.94 [0.68-1.31],0.7089665252979738
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23660,51,0.97 [0.71-1.33],0.8417114879650938
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23761,460,0.94 [0.85-1.05],0.2895423421789009
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23590,289,1.01 [0.89-1.15],0.8405351890374246
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23384,83,1.04 [0.82-1.32],0.7577230428418358
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23367,66,0.94 [0.70-1.25],0.6651542926809078
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Acute pharyngitis,23588,69,0.92 [0.70-1.22],0.5836694262277775
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23729,210,0.94 [0.80-1.10],0.4320715571393364
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23574,55,0.88 [0.63-1.22],0.4358746378044177
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,All influenza,22722,69,1.22 [0.98-1.53],0.0755911951328783
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22721,68,1.25 [1.00-1.55],0.0520262119515417
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17629,117,1.07 [0.88-1.29],0.4910632350060516
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Allergic rhinitis,23716,272,1.09 [0.96-1.23],0.1737524672601133
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18910,1527,0.99 [0.93-1.05],0.6784164450263956
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19013,1501,0.99 [0.93-1.05],0.6734254215556845
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23596,84,1.08 [0.86-1.35],0.5216409677498879
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22703,50,1.08 [0.80-1.45],0.6154257287906473
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Bronchiectasis,21201,155,1.07 [0.90-1.27],0.4283771828501568
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21080,34,0.92 [0.61-1.38],0.680220960180969
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23077,2031,1.00 [0.95-1.05],0.9190791254295464
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22559,58,0.96 [0.71-1.29],0.7835930862253648
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Chronic sinusitis,22644,143,1.09 [0.92-1.30],0.3053723086987772
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23752,615,1.03 [0.94-1.12],0.5201076041551558
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Deviated nasal septum,22622,121,0.98 [0.80-1.20],0.8444444464232461
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22158,3671,1.01 [0.97-1.05],0.6211239205540706
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22839,338,1.01 [0.89-1.13],0.9086252956603168
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Early onset COPD,23577,440,1.01 [0.91-1.12],0.8931245550056428
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Emphysema,21205,159,1.02 [0.85-1.21],0.8632805464807943
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22728,100,0.85 [0.67-1.09],0.2128166258937782
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23684,1031,1.00 [0.93-1.07],0.9329160767195672
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Interstitial lung disease,22748,120,0.89 [0.71-1.11],0.2984027063044079
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Later onset COPD,22583,175,1.08 [0.92-1.26],0.3414702256301122
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23836,132,0.96 [0.78-1.17],0.6666168706934649
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Nasal polyp,22603,102,1.04 [0.84-1.28],0.71723406606139
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23650,548,1.00 [0.91-1.10],0.9730331059123688
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other diseases of pleura,23688,1083,0.99 [0.93-1.06],0.8844644611925546
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23276,775,1.07 [0.99-1.15],0.0765902965690723
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other pleural conditions,22638,33,0.86 [0.56-1.32],0.4920592341207216
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23791,176,0.83 [0.69-1.01],0.0610757944342947
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23773,743,0.99 [0.91-1.08],0.8469235894462539
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pleural effusion,23122,517,1.00 [0.91-1.11],0.9419007264543188
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pleural plaque,22652,47,0.90 [0.64-1.27],0.5442689449812621
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23499,846,0.97 [0.90-1.05],0.4305817243350989
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23819,115,0.92 [0.74-1.14],0.4427352790958151
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pneumothorax,22660,55,1.03 [0.78-1.37],0.8320044072413171
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pollen allergy,23812,232,1.10 [0.96-1.25],0.175499648291219
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pulmonary oedema,23651,36,0.67 [0.41-1.07],0.0931757830721657
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17544,32,1.28 [0.93-1.76],0.1249039645239481
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23630,528,0.99 [0.90-1.09],0.8235618097488902
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22773,272,1.09 [0.97-1.23],0.1627474667457661
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Viral pneumonia,22819,166,0.95 [0.80-1.14],0.590317222377447
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23613,143,0.94 [0.77-1.14],0.5180847989475825
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13726,82,0.88 [0.68-1.15],0.3579092438927772
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18233,56,0.98 [0.73-1.32],0.9138455767667724
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute appendicitis,23668,133,0.91 [0.75-1.12],0.3787788709452954
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute gastritis,19051,60,1.07 [0.82-1.40],0.6117851535564585
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute pancreatitis,22449,148,1.11 [0.94-1.31],0.2065438232249115
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute peritonitis,23460,58,1.24 [0.97-1.57],0.0808337317546597
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23169,73,0.98 [0.75-1.27],0.8668203860468511
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Barrett oesophagus,19298,307,0.97 [0.86-1.11],0.68651131246213
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22350,49,1.12 [0.84-1.49],0.447848221431482
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23491,49,1.12 [0.84-1.49],0.4540087839584624
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Cholecystitis,22457,156,0.93 [0.77-1.12],0.4571353390681337
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Cholelithiasis,23110,809,0.99 [0.91-1.07],0.7743845774726273
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Chronic gastritis,19206,215,1.04 [0.90-1.20],0.6216811695647217
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22339,38,0.91 [0.62-1.34],0.6388168149593743
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23716,72,0.90 [0.68-1.20],0.4765317232509646
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Coeliac disease,22599,97,1.16 [0.96-1.41],0.128173702138085
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Collagenous colitis,22487,48,1.02 [0.75-1.39],0.8957401439162342
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23673,179,0.97 [0.82-1.15],0.7114468133512837
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Constipation,23658,1004,1.02 [0.95-1.09],0.5652933673132918
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Crohn disease,22518,79,0.91 [0.70-1.19],0.4995011057981392
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23540,53,0.99 [0.73-1.35],0.9625497900270324
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22516,77,0.96 [0.74-1.24],0.751003596696482
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Dental caries,23123,227,1.05 [0.91-1.21],0.4967922392957756
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22033,1550,0.99 [0.94-1.05],0.8216409005100972
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of appendix,23706,171,1.03 [0.88-1.21],0.7217345030498648
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of liver,23739,643,1.00 [0.92-1.09],0.9972148570861302
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22320,3329,1.00 [0.96-1.04],0.9872208464340064
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23425,529,1.09 [1.00-1.19],0.0628851293520053
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23773,371,1.13 [1.02-1.26],0.0168258782782325
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23009,113,1.12 [0.93-1.35],0.2486145260238684
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22874,60,0.94 [0.70-1.27],0.6875299557570425
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23599,1097,1.03 [0.96-1.10],0.4097951930498401
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of tongue,22879,107,1.09 [0.90-1.33],0.3732050484788928
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23397,1096,1.00 [0.93-1.06],0.8921928155675681
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20293,2116,1.01 [0.97-1.06],0.6203827138503
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Duodenal ulcer,19121,130,1.04 [0.87-1.25],0.6571212933306212
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23780,101,1.06 [0.86-1.31],0.5690837190710021
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23725,73,1.22 [0.98-1.50],0.0700783305618167
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23186,90,0.94 [0.73-1.20],0.603607850980356
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18330,153,0.96 [0.80-1.15],0.6455612905788045
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Functional dyspepsia,19435,444,1.00 [0.90-1.11],0.9678386898294772
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastric ulcer,19240,249,0.98 [0.85-1.13],0.7628236125125272
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20927,1936,0.99 [0.94-1.04],0.6930151470587711
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19354,363,1.01 [0.91-1.14],0.799187364190735
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19410,6918,1.00 [0.98-1.03],0.9298673866114876
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,GI-bleeding,23376,874,1.00 [0.93-1.08],0.9196294463364958
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22956,60,1.18 [0.92-1.51],0.1891725223458126
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18958,1101,1.08 [1.02-1.15],0.0100400011933608
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23142,46,0.91 [0.64-1.29],0.5897530222763174
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Hernia,22826,2343,1.01 [0.96-1.05],0.8034923734081558
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Impacted teeth,23734,68,1.16 [0.92-1.46],0.1990780457926322
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Impaction of intestines,18207,30,0.94 [0.62-1.42],0.7571387875697276
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Inguinal hernia,21074,591,1.01 [0.93-1.11],0.7774000269369227
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20552,69,1.00 [0.77-1.30],0.9960167873227316
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18240,63,0.91 [0.68-1.23],0.5468380355255742
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22618,116,1.19 [1.00-1.41],0.056835738417508
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18680,503,1.00 [0.91-1.11],0.9312835315065574
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23819,334,1.00 [0.88-1.12],0.9522103336059292
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23041,602,1.06 [0.97-1.15],0.2037748958987295
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23199,760,1.04 [0.96-1.12],0.376620480252159
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19117,126,1.03 [0.85-1.24],0.7919480844027666
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Oesophagitis,19415,424,1.03 [0.93-1.15],0.5400197743362309
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23806,116,0.93 [0.75-1.15],0.480197063756946
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20526,43,1.16 [0.87-1.55],0.3171403088604156
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19309,1132,1.01 [0.94-1.07],0.8385466566630271
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22469,168,0.95 [0.79-1.13],0.5505984571675888
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22440,139,1.05 [0.88-1.25],0.5967628596903214
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of intestine,19499,1322,1.02 [0.96-1.08],0.5633142276336389
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of intestines,22407,4230,1.01 [0.97-1.04],0.7018728809774556
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22881,167,0.91 [0.76-1.09],0.3035187943420794
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of liver,23611,515,0.99 [0.90-1.10],0.9170204533942492
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19459,468,1.00 [0.90-1.10],0.9379098786781312
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22371,70,1.07 [0.83-1.37],0.6170150262391154
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23728,326,1.12 [1.00-1.25],0.0454853308312939
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19657,666,1.00 [0.92-1.09],0.94193417368269
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23389,887,1.01 [0.94-1.08],0.8520024369436395
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23042,146,1.03 [0.86-1.23],0.7375482312719406
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19223,1046,1.03 [0.96-1.10],0.4013263039107771
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20513,1522,1.00 [0.95-1.06],0.921172373542488
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23167,71,1.04 [0.81-1.34],0.7734289855862762
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23100,661,1.04 [0.96-1.13],0.3320032036950407
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18380,203,0.99 [0.84-1.15],0.8629582848242506
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23711,86,1.29 [1.07-1.55],0.0067408671414448
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18480,303,0.99 [0.87-1.12],0.8674211590429707
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22627,125,0.99 [0.81-1.20],0.8957922837200629
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23834,55,0.92 [0.67-1.26],0.5872525466193835
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22910,117,1.00 [0.81-1.22],0.9706995935476638
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Toxic colitis,22460,21,0.78 [0.44-1.38],0.3994067810892552
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19156,165,1.09 [0.93-1.27],0.31067415929758
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Ulcerative colitis,22568,129,0.97 [0.80-1.18],0.7811142766265534
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22550,111,0.97 [0.78-1.19],0.7447734416606766
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Umbilical hernia,20717,234,1.01 [0.88-1.17],0.8720594266706906
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18270,93,1.12 [0.91-1.38],0.2725223001626562
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Ventral hernia,20682,199,0.99 [0.85-1.16],0.9388420407917648
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Volvulus,18235,58,0.92 [0.68-1.25],0.6059812307202657
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23804,136,0.94 [0.77-1.15],0.540482113934455
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23611,72,1.16 [0.93-1.46],0.1960971563791248
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22559,131,0.95 [0.77-1.16],0.5894663681960135
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23281,479,0.93 [0.83-1.03],0.1782091116564101
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22981,179,1.07 [0.92-1.25],0.3971024097697105
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22574,146,1.12 [0.95-1.33],0.1680688480565034
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23618,202,1.02 [0.88-1.19],0.8020219061079127
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23757,341,1.02 [0.91-1.15],0.7369512308602403
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23452,36,1.09 [0.78-1.53],0.6143836765924604
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22564,2216,1.01 [0.96-1.06],0.7183461224724972
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23440,369,1.01 [0.90-1.13],0.8252057738828117
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23328,257,1.01 [0.88-1.16],0.8827606183125845
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23490,688,0.96 [0.88-1.05],0.3962037529856586
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23831,40,0.86 [0.58-1.26],0.4292640630459149
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22482,54,0.87 [0.63-1.22],0.4236995659522294
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23108,37,1.06 [0.75-1.50],0.7321508753593021
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23612,196,1.00 [0.86-1.17],0.9697440248144912
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22683,255,1.01 [0.88-1.16],0.9018836492734824
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22462,34,1.02 [0.70-1.47],0.9368335291390713
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23773,62,0.88 [0.64-1.19],0.4043328976348832
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22919,117,0.92 [0.74-1.15],0.4687765750920616
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23673,134,0.76 [0.61-0.96],0.0199374075838962
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23440,24,0.91 [0.56-1.49],0.7084955943928772
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22474,46,0.75 [0.51-1.11],0.1506192726287757
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23391,963,1.03 [0.96-1.10],0.4847678044972006
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22713,285,1.00 [0.88-1.13],0.9579406957673272
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22465,37,1.08 [0.77-1.52],0.646359828541393
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23772,233,0.95 [0.82-1.10],0.5031287916596738
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23471,55,0.94 [0.68-1.28],0.684316865935823
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23730,191,0.96 [0.82-1.13],0.6461906189156086
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23817,149,0.95 [0.79-1.15],0.5992266017787742
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22538,110,1.00 [0.82-1.24],0.9696292129876634
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22596,168,1.10 [0.94-1.29],0.2211849943597164
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23812,144,0.94 [0.78-1.14],0.5367852452295072
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22542,114,0.91 [0.73-1.14],0.4059993946362819
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23815,104,0.96 [0.77-1.20],0.7060792529743389
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20890,117,0.88 [0.70-1.10],0.2486894841637564
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22234,4024,1.01 [0.97-1.04],0.6627860093855588
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21075,2865,1.03 [0.99-1.08],0.0976796198535081
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20858,85,1.09 [0.87-1.36],0.4437363511832632
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21363,135,1.02 [0.85-1.23],0.8033866458468221
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21370,142,1.01 [0.84-1.21],0.9478944267133588
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23644,101,0.85 [0.67-1.09],0.2078496780588831
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21271,43,0.98 [0.69-1.38],0.8989609883675824
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18873,663,1.02 [0.94-1.11],0.6092783944569251
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23789,114,0.91 [0.73-1.14],0.4120189068663882
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21480,252,1.18 [1.05-1.33],0.0071075282457318
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20819,5392,1.01 [0.98-1.04],0.696419388285832
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22635,92,1.07 [0.86-1.33],0.5416293655506519
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20875,102,0.92 [0.73-1.16],0.4746969901906093
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21310,537,1.04 [0.95-1.14],0.3627709698396956
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23057,1829,1.06 [1.01-1.12],0.01609230321585
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20974,201,1.18 [1.03-1.34],0.0156340259061719
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21033,260,1.11 [0.98-1.26],0.1065839151845936
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20908,135,1.14 [0.96-1.35],0.1299516599966881
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23378,34,0.86 [0.57-1.32],0.4961071979092464
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19341,1131,1.02 [0.96-1.09],0.4789399775985811
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18550,340,0.91 [0.80-1.03],0.1377053474697299
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23795,330,0.91 [0.80-1.04],0.1588122125879598
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18277,67,0.98 [0.74-1.29],0.8838487588689163
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18513,303,0.99 [0.87-1.13],0.8715622056683805
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21061,288,0.99 [0.87-1.13],0.8784927025806037
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18869,659,1.02 [0.93-1.11],0.6987481642346829
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21253,25,0.92 [0.58-1.47],0.7390213109161924
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21715,487,1.05 [0.96-1.16],0.2835213281427325
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21477,249,1.00 [0.87-1.15],0.9776082961275554
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18822,612,1.03 [0.94-1.12],0.5029629971143668
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20843,70,1.13 [0.89-1.43],0.3239150382025887
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20826,53,1.06 [0.80-1.41],0.68849038693384
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22593,50,0.90 [0.64-1.26],0.535808358280556
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23551,1008,1.03 [0.97-1.11],0.3288698427751519
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23117,574,1.06 [0.97-1.16],0.2001910243293742
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23737,301,0.93 [0.81-1.07],0.2997021159163646
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19764,1554,1.05 [1.00-1.11],0.0512134840201382
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18273,63,0.97 [0.73-1.29],0.8273133406160604
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20841,68,1.11 [0.87-1.42],0.4036916933279791
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18235,25,1.00 [0.65-1.55],0.9946354611402802
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18307,97,1.06 [0.86-1.32],0.5720797547675652
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22745,202,0.95 [0.80-1.11],0.4961157371252527
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22754,211,1.10 [0.95-1.26],0.2019312756762279
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23807,74,1.01 [0.78-1.30],0.9597782138381888
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22590,1362,1.04 [0.98-1.10],0.1710954518500086
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20880,107,0.94 [0.75-1.18],0.6037249933625459
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18319,109,0.96 [0.77-1.19],0.6941591204169026
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21783,555,1.07 [0.98-1.17],0.1464744517439433
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19989,1779,1.01 [0.96-1.06],0.7019880005855773
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23396,52,1.16 [0.89-1.52],0.2740093193185227
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23819,69,1.19 [0.95-1.50],0.1324652942446826
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20843,70,1.03 [0.80-1.34],0.7957409866011684
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21737,964,1.05 [0.98-1.12],0.1943305993249999
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20832,59,0.87 [0.63-1.20],0.3910927570798039
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19177,967,1.02 [0.95-1.09],0.5944948485174695
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22635,92,1.01 [0.80-1.27],0.9457971587692648
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20832,59,0.96 [0.72-1.29],0.7965876427308827
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21331,103,1.09 [0.89-1.33],0.4142556891244704
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21117,344,1.04 [0.93-1.17],0.4565982216912332
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23534,190,1.09 [0.93-1.26],0.2838470392276814
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21639,411,1.02 [0.92-1.14],0.7001748076645813
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23746,286,0.93 [0.81-1.07],0.3176544208947392
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23827,33,1.03 [0.71-1.50],0.8577672006017186
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20954,181,1.07 [0.92-1.25],0.3596089740748366
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19108,532,0.96 [0.87-1.07],0.4786489680131576
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21205,432,0.97 [0.87-1.09],0.6317598130350247
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20922,149,1.16 [1.00-1.36],0.0527207249401571
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18243,33,0.79 [0.50-1.25],0.3048461683753466
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19743,1533,0.99 [0.94-1.05],0.8337583905393068
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18602,392,0.97 [0.87-1.09],0.6668009384069372
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23421,77,1.17 [0.94-1.46],0.1481614519949025
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23776,43,1.08 [0.78-1.48],0.6552324679161603
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22448,24,1.41 [1.01-1.96],0.0425271346067225
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18281,71,1.19 [0.95-1.50],0.1234085201863881
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21306,78,0.93 [0.71-1.21],0.5790731274885381
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18514,304,0.97 [0.85-1.10],0.6182456021281508
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21010,237,0.94 [0.81-1.10],0.4426831630368137
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21414,186,1.23 [1.07-1.40],0.0029797144916847
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21321,93,1.14 [0.94-1.40],0.1900628548710708
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20152,41,1.02 [0.73-1.43],0.9002101002299019
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23830,36,1.07 [0.76-1.52],0.6891880861226557
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21297,524,0.92 [0.83-1.02],0.1283040785031498
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23422,78,1.10 [0.87-1.38],0.4328354917492425
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22900,2127,1.03 [0.98-1.08],0.2755913363936697
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20874,101,0.92 [0.73-1.16],0.4912814782366952
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21544,316,1.06 [0.94-1.20],0.3072088434095295
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22613,167,1.10 [0.94-1.29],0.2426887177031351
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21359,131,1.21 [1.03-1.42],0.0237010120433899
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22165,937,1.07 [1.00-1.15],0.0388744570356383
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21841,613,1.06 [0.98-1.16],0.1492227025050809
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20812,39,1.18 [0.86-1.60],0.304956695413368
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23478,134,1.02 [0.85-1.23],0.840113471070078
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20907,134,1.02 [0.84-1.23],0.843145754453149
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20826,53,0.84 [0.59-1.18],0.3122680075682735
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18243,33,0.92 [0.61-1.39],0.7070947513216058
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23392,726,1.00 [0.92-1.09],0.9768080582851668
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9660,63,0.96 [0.72-1.27],0.7556886697647432
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12877,70,0.95 [0.72-1.25],0.7168912099534398
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23581,268,1.00 [0.87-1.15],0.9877537473502916
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23369,56,0.54 [0.36-0.82],0.003412436452723
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23216,550,1.08 [0.99-1.18],0.0933811319424339
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23690,18,0.49 [0.23-1.04],0.061476392116759
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23698,157,0.98 [0.82-1.17],0.8358480538805805
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Cystitis,21891,135,0.95 [0.78-1.15],0.5834638965492087
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Dialysis,22707,41,1.12 [0.82-1.53],0.4922779347412541
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10304,982,1.02 [0.95-1.09],0.5276452528381086
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12980,173,0.89 [0.74-1.07],0.2188318896296874
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Endometriosis,9712,115,0.91 [0.73-1.13],0.3779491108814656
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9927,330,0.86 [0.76-0.99],0.0304685799690935
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9973,376,1.10 [0.99-1.22],0.0886506324192579
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20064,3663,1.04 [1.00-1.07],0.0501829859443566
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23726,54,1.26 [0.99-1.60],0.0624155263712715
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Hydrocele,9394,72,0.95 [0.73-1.24],0.7277334726096784
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22592,191,0.96 [0.82-1.13],0.6531922813930513
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9975,653,1.02 [0.94-1.11],0.6138165547470773
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12864,206,0.98 [0.84-1.15],0.8443765220851905
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9413,91,1.16 [0.95-1.42],0.137314739833185
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Irregular menses,12874,106,0.77 [0.60-0.99],0.0421869334159174
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9856,259,0.91 [0.78-1.05],0.1821364628360152
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21813,57,1.17 [0.90-1.50],0.2422265104238739
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10806,1209,1.03 [0.97-1.10],0.3338104068571665
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9369,47,0.90 [0.64-1.27],0.5573583587546509
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9680,83,1.02 [0.80-1.29],0.886788613702527
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23834,35,1.25 [0.92-1.70],0.152263763958254
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23838,39,0.90 [0.62-1.32],0.6037880343136874
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23082,1326,1.04 [0.98-1.10],0.231685958829078
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22176,420,1.08 [0.97-1.19],0.148974187050471
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12860,53,0.82 [0.58-1.16],0.2692369321425892
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23800,259,1.09 [0.96-1.24],0.1649428137146213
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9458,136,0.90 [0.74-1.11],0.3245656330790032
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9427,105,1.08 [0.89-1.32],0.4170355122639222
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9387,65,0.94 [0.71-1.24],0.6508299346805039
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23812,49,1.07 [0.79-1.44],0.6587150830420692
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22727,971,1.02 [0.95-1.09],0.5611071192439392
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12763,105,0.99 [0.80-1.23],0.9478313371213762
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9668,71,1.03 [0.80-1.33],0.8127618332732707
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9795,198,0.96 [0.82-1.13],0.6294585715570282
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9648,51,1.06 [0.79-1.42],0.7180811837674386
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9686,89,1.07 [0.86-1.34],0.5510986494558461
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22622,221,0.93 [0.79-1.09],0.3493360774361804
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23629,88,1.20 [0.98-1.47],0.0706852569314671
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9752,155,1.02 [0.85-1.21],0.8655854736583988
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9666,69,0.89 [0.66-1.19],0.4161612342830323
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9953,356,1.00 [0.89-1.12],0.9859754627875742
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9652,55,0.95 [0.70-1.30],0.7561651652840405
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9915,318,0.99 [0.88-1.13],0.9368124128385884
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23714,42,1.00 [0.71-1.41],0.9953440960319734
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9418,96,1.04 [0.84-1.28],0.7286299969931516
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23687,1286,1.03 [0.97-1.09],0.3428617509903589
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22521,120,1.06 [0.88-1.29],0.527244377971259
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22720,54,0.98 [0.72-1.33],0.8770711059228473
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23374,61,1.27 [1.01-1.59],0.0406722621985363
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21905,149,1.07 [0.90-1.26],0.4614775705548806
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23639,326,0.99 [0.88-1.12],0.8775452830629475
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9681,84,1.04 [0.83-1.31],0.7303118677582952
